Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunomodulating activity of pidotimod

G Migliorati1, I Nicoletti, C Riccardi

  • 1Institute of Pharmacology, School of Medicine, University of Perugia, Italy.

Arzneimittel-Forschung
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observation of the ϒ(3S) Meson and Suppression of ϒ States in Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2024
Same author

Search for Narrow Trijet Resonances in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2024
Same author

Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.

Physical review letters·2024
Same author

Search for Baryon Number Violation in Top Quark Production and Decay Using Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2024
Same author

Search for exotic decays of the Higgs boson to a pair of pseudoscalars in the <math></math> and <math></math> final states.

The European physical journal. C, Particles and fields·2024
Same author

Observation of WWγ Production and Search for Hγ Production in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2024
Same journal

Wirksamkeit und Verträglichkeit eines pflanzlichen Arzneimittels mit Kapuzinerkressenkraut und Meerrettich bei akuter Sinusitis, akuter Bronchitis und akuter Blasenentzündung im Vergleich zu anderen Therapien unter den Bedingungen der täglichen Praxis.

Arzneimittel-Forschung·2013
Same journal

Abstracts of the Paul-Martini-Stiftung Symposium 2012 in combination with the National Academy of Leopoldina. November 16-17, 2012. Berlin, Germany.

Arzneimittel-Forschung·2013
Same journal

Leave-one-out procedure in the validation of elimination rate constant analysis.

Arzneimittel-Forschung·2012
Same journal

Pharmacokinetic and myocardial enzyme profiles of two administration routes of epirubicin in breast cancer patients.

Arzneimittel-Forschung·2012
Same journal

Synthesis, anti-hypertensive effect of a novel angiotensin II AT1 receptor antagonist and its anti-tumor activity in prostate cancer.

Arzneimittel-Forschung·2012
Same journal

Effect of zeolite nano-materials and artichoke (Cynara scolymus L.) leaf extract on increase in urinary clearance of systematically absorbed nicotine.

Arzneimittel-Forschung·2012
See all related articles

Pidotimod enhances immune responses by boosting T-cell proliferation and natural killer (NK) cell activity in mice. This immunomodulating agent also effectively inhibits thymocyte apoptosis in vitro.

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • The immunomodulating agent pidotimod is a synthetic compound with potential therapeutic applications.
  • Understanding its effects on immune cell function is crucial for evaluating its efficacy.

Purpose of the Study:

  • To investigate the impact of pidotimod on mouse splenic proliferative responses, natural killer (NK) cell activity, and thymocyte apoptosis.

Main Methods:

  • Mice were treated in vivo with pidotimod (200 mg/kg i.p. for 5 days).
  • Splenic proliferative responses to Con-A and IL-2 were measured.
  • NK cell activity was assessed.
  • Thymocyte apoptosis was induced in vitro using various agents and assessed in the presence of pidotimod.

Main Results:

Related Experiment Videos

  • In vivo pidotimod treatment significantly increased the proliferative response to mitogens like Con-A and IL-2.
  • Cytotoxic activity mediated by NK cells was enhanced following pidotimod administration.
  • Pidotimod demonstrated an inhibitory effect on in vitro thymocyte apoptosis induced by agents such as PMA, A23187, genistein, and IL-2.

    • Conclusions:

    • Pidotimod exhibits significant immunomodulatory effects in vivo, enhancing T-cell proliferation and NK cell-mediated cytotoxicity.
    • The compound also possesses protective properties against apoptosis in thymocytes in vitro.